Effects of synbiotic supplementation on the components of metabolic syndrome in military personnel: a double-blind randomised controlled trial

被引:10
作者
Parastouei, Karim [1 ]
Saeidipoor, S. [2 ]
Sepandi, M. [1 ]
Abbaszadeh, S. [1 ]
Taghdir, M. [1 ,2 ]
机构
[1] Baqiyatallah Univ Med Sci, Hlth Res Ctr, Life Style Inst, Tehran 14359113189, Iran
[2] Baqiyatallah Univ Med Sci, Fac Hlth, Dept Nutr & Food Hyg, Tehran, Iran
关键词
GUT MICROBIOTA; INSULIN-RESISTANCE; PROBIOTIC SUPPLEMENTATION; RISK-FACTORS; HIGH-FAT; DISEASE; CONSUMPTION; PEPTIDES; OBESITY;
D O I
10.1136/bmjmilitary-2020-001459
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Metabolic syndrome comprises a set of risk factors for chronic diseases including abdominal obesity, increased fasting blood glucose (FBG), altered lipid profile and elevated blood pressure (BP). Due to high prevalence of metabolic syndrome and its complications in the military personnel, the relevant problems should be identified and controlled. Therefore, the present study was conducted to determine the effect of synbiotic supplements on the components of metabolic syndrome in the military personnel with metabolic syndrome. Methodology Sixty military personnel with metabolic syndrome were included in this double-blind randomised controlled clinical trial. During the intervention, they were asked to consume one capsule of synbiotic supplement or placebo per day for 8 weeks. Body Mass Index (BMI), waist circumference, BP, FBG and lipid profile were measured before and after the intervention. Results The results of the study showed that the synbiotic supplementation had a large significant adjusted effect on the BMI (Cohen's d=0.82 (95% CI 0.29 to 1.34)). It also had a medium significant adjusted effect on the FBG (Cohen's d=0.52 (95% CI 0.004 to 1.03)) as well as triglyceride (Cohen's d=0.65 (95% CI 0.13 to 1.17)). Conclusion Findings of the study revealed that synbiotic supplementation may lead to a significant improvement in the BMI, triglyceride and FBG levels in the military personnel. Thus, consumption of synbiotic supplements is recommended as an adjuvant therapy in the military personnel with metabolic syndrome.
引用
收藏
页码:362 / 367
页数:6
相关论文
共 42 条
[1]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[2]  
Andersen C, 2004, METABOLIC SYNDROME A
[3]  
[Anonymous], 2001, HLTH NUTR PROP PROB
[4]   Effect of multispecies probiotic supplements on serum minerals, liver enzymes and blood pressure in patients with type 2 diabetes [J].
Asemi, Zatollah ;
Bahmani, Sahar ;
Shakeri, Hossein ;
Jamal, Atefeh ;
Faraji, Ali-Mohammad .
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2015, 35 (02) :90-95
[5]  
Burcelin R., 2015, Metabonomics and Gut Microbiota in Nutrition and Disease. Molecular and Integrative Toxicology, P199, DOI DOI 10.1007/978-1-4471-6539-2_11
[6]   Novel opportunities for next-generation probiotics targeting metabolic syndrome [J].
Cani, Patrice D. ;
Van Hul, Matthias .
CURRENT OPINION IN BIOTECHNOLOGY, 2015, 32 :21-27
[7]   Gut-liver axis: The impact of gut microbiota on non alcoholic fatty liver disease [J].
Compare, D. ;
Coccoli, P. ;
Rocco, A. ;
Nardone, O. M. ;
De Maria, S. ;
Carteni, M. ;
Nardone, G. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2012, 22 (06) :471-476
[8]   The metabolic syndrome [J].
Eckel, RH ;
Grundy, SM ;
Zimmet, PZ .
LANCET, 2005, 365 (9468) :1415-1428
[9]   Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study [J].
Eslamparast, Tannaz ;
Zamani, Farhad ;
Hekmatdoost, Azita ;
Sharafkhah, Maryam ;
Eghtesad, Sareh ;
Malekzadeh, Reza ;
Poustchi, Hossein .
BRITISH JOURNAL OF NUTRITION, 2014, 112 (03) :438-445
[10]   Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance? [J].
Esteve, Eduardo ;
Ricart, Wifredo ;
Fernandez-Real, Jose-Manuel .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2011, 14 (05) :483-490